Cobblestone Lissencephaly: Clinical Trials

4 trials for Cobblestone Lissencephaly, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 unknown. .

Follow Cobblestone Lissencephaly: new trials by email Literature Review of Cobblestone Lissencephaly trials Research Report on Cobblestone Lissencephaly

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Term Development of Muscular Dystrophy Outcome Assessments
LGMD1B, LGMD1C
RecruitingVirginia Commonwealth University10002023-10-182025-11-18
Global FKRP Registry
Patient Registry - LGMD2I, LGMDR9
UnknownNewcastle University10002013-11-012024-01-30
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency, Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)
RecruitingCure CMD40002009-09-012021-08-09
Clinical Trial Readiness for the Dystroglycanopathies
Muscular Dystrophy
RecruitingKatherine Mathews1902006-04-012025-07-30

Narrower conditions

Walker-Warburg Syndrome (4)  ·  Muscular Dystrophies, Limb-Girdle (3)  ·  Muscular Dystrophy, Limb-Girdle, Type 2I (3)  ·  Muscular Dystrophy, Limb-Girdle, Type 2M (3)  ·  Muscular Dystrophies (2)  ·  Muscular Dystrophy, Limb-Girdle, Type 2G (2)  ·  Epilepsy (1)  ·  Intellectual Disability (1)  ·  Limb-Girdle Muscular Dystrophy, Type 1G (1)  ·  Limb-girdle muscular dystrophy type 2A (1)  ·  Limb-girdle muscular dystrophy type 2F (1)  ·  Limb-girdle muscular dystrophy, type 1B (1)  ·  Limb-girdle muscular dystrophy, type 2B (1)  ·  Limb-girdle muscular dystrophy, type 2C (1)  ·  Limb-girdle muscular dystrophy, type 2E (1)

Broader conditions

Congenital Abnormalities (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Eye Diseases (4)  ·  Eye Diseases, Hereditary (4)  ·  Genetic Diseases, Inborn (4)  ·  Lissencephaly (4)  ·  Malformations of Cortical Development (4)  ·  Malformations of Cortical Development, Group II (4)  ·  Muscular Diseases (4)  ·  Muscular Disorders, Atrophic (4)  ·  Nervous System Diseases (4)  ·  Nervous System Malformations (4)  ·  Musculoskeletal Diseases (3)  ·  Neuromuscular Diseases (3)

Sponsors

Cure CMD (1)  ·  Katherine Mathews (1)  ·  Newcastle University (1)  ·  Virginia Commonwealth University (1)

Countries

United States (3)  ·  United Kingdom (1)

Top investigators

Gustavo Dziewczapolski, PhD (1)  ·  Katherine Mathews, M.D. (1)  ·  Kevin Campbell, Ph.D. (1)  ·  Nicholas Johnson, MD (1)  ·  Steven A. Moore, M.D. Ph.D. (1)  ·  Volker Straub, MD, PhD (1)

Results publications

PMID 20646909, PMID 21220724, PMID 25568299, PMID 26310427, PMID 27872178, PMID 28087826, PMID 29101272, PMID 29759639, PMID 31041397, PMID 32115343, PMID 32764098, PMID 32914449, PMID 33501999, PMID 34857438, PMID 36399172, PMID 37247532, PMID 40245099, PMID 41486779

NIH funding

U54NS053672 (1)